☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Commercialisation
AstraZeneca Signs Development and Commercialization Agreement with Kyowa Hakko Kirin for its Fasenra (beralizumab)
March 26, 2019
Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab- biosimilar) in Finland
October 25, 2018
Astrazeneca Expands Existing Deal with Innate Pharma to Strengthen its Oncology Pipeline
October 23, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
